Fundsmith Llp Stake in Idexx Laboratories (IDXX) Has Decreased as Valuation Declined; Chieftain Capital Management Position in Cbs New (CBS) Has Trimmed by $2.80 Million as Market Valuation Declined

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Logo

Fundsmith Llp decreased its stake in Idexx Laboratories (IDXX) by 0.06% based on its latest 2018Q3 regulatory filing with the SEC. Fundsmith Llp sold 2,461 shares as the company’s stock declined 20.36% with the market. The institutional investor held 4.43M shares of the health care company at the end of 2018Q3, valued at $1.11B, down from 4.43 million at the end of the previous reported quarter. Fundsmith Llp who had been investing in Idexx Laboratories for a number of months, seems to be less bullish one the $18.14 billion market cap company. The stock increased 0.42% or $0.89 during the last trading session, reaching $210.39. About 382,737 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 22.67% since February 14, 2018 and is uptrending. It has outperformed by 22.67% the S&P500.

Chieftain Capital Management Inc decreased its stake in Cbs Corp New (CBS) by 1.75% based on its latest 2018Q3 regulatory filing with the SEC. Chieftain Capital Management Inc sold 49,160 shares as the company’s stock declined 9.86% with the market. The hedge fund held 2.75M shares of the broadcasting company at the end of 2018Q3, valued at $158.16 million, down from 2.80 million at the end of the previous reported quarter. Chieftain Capital Management Inc who had been investing in Cbs Corp New for a number of months, seems to be less bullish one the $18.12 billion market cap company. The stock increased 0.10% or $0.05 during the last trading session, reaching $48.43. About 3.07 million shares traded. CBS Corporation (NYSE:CBS) has declined 13.01% since February 14, 2018 and is downtrending. It has underperformed by 13.01% the S&P500. Some Historical CBS News: 17/05/2018 – CBS votes to end Redstone control, needs court approval; 02/04/2018 – IF CBS, VIACOM MERGE, MOONVES TO OFFER TO STAY 2 YRS: RTRS/CNBC; 01/04/2018 – Simply Telecom: Exclusive: Viacom, CBS CEOs discuss potential merger; 14/05/2018 – Deadline Hollywd: Verizon Expressed Interest In Acquiring CBS Before Viacom Talks Heated Up; 16/05/2018 – Judge Hits Pause on War Between CBS and Its Parent Company; 25/04/2018 – VIACOM: WON’T ANSWER QUESTIONS ABOUT CBS MERGER PROCESS; 14/05/2018 – REDSTONE TOLD CEO OF POSSIBLE CBS BIDDER NOT TO MAKE OFFER; 14/05/2018 – CBS Says National Amusements Sought to Interfere With Special Board Meeting to Declare Dividend; 18/03/2018 – Republican senator expects Trump to pull out of Iran deal -CBS; 18/05/2018 – Dealpolitik: CBS Directors Play a Subtle Game in Viacom Battle

More notable recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were published by: Nasdaq.com which released: “ZBH & IDXX Q4 Earnings on Feb 1: Here are the Key Predictions – Nasdaq” on January 31, 2019, also Fool.com with their article: “Why Idexx Laboratories Stock Gained 19% in 2018 – Motley Fool” published on January 11, 2019, Nasdaq.com published: “Consolidated Research: 2019 Summary Expectations for First Data, IDEXX Laboratories, CMS Energy, Worthington Industries, Triumph Group, and Cara Therapeutics — Fundamental Analysis, Key Performance Indications – Nasdaq” on January 24, 2019. More interesting news about IDEXX Laboratories, Inc. (NASDAQ:IDXX) were released by: Nasdaq.com and their article: “Here’s Why Momentum Investors Will Love Idexx Laboratories (IDXX) – Nasdaq” published on February 13, 2019 as well as Nasdaq.com‘s news article titled: “Friday 2/8 Insider Buying Report: ADM, IDXX – Nasdaq” with publication date: February 08, 2019.

Fundsmith Llp, which manages about $2.92 billion and $14.91B US Long portfolio, upped its stake in Waters Corp (NYSE:WAT) by 297,565 shares to 5.03M shares, valued at $978.57M in 2018Q3, according to the filing. It also increased its holding in Johnson & Johnson (NYSE:JNJ) by 25,716 shares in the quarter, for a total of 4.58M shares, and has risen its stake in Stryker Corp (NYSE:SYK).

Investors sentiment increased to 1.04 in 2018 Q3. Its up 0.03, from 1.01 in 2018Q2. It increased, as 25 investors sold IDXX shares while 207 reduced holdings. 82 funds opened positions while 159 raised stakes. 70.63 million shares or 1.73% less from 71.88 million shares in 2018Q2 were reported. Zebra Capital Mgmt Ltd Limited Liability Company accumulated 2,601 shares. 30,371 were reported by Wendell David Associate. Woodstock reported 46,478 shares stake. Mgmt Inc has invested 5.3% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Amp Invsts invested 0.08% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Biondo Invest Ltd Liability Corp stated it has 64,706 shares. Jacobs Levy Equity Mngmt holds 0.35% or 99,595 shares in its portfolio. Qcm Cayman Ltd holds 1.16% or 1,416 shares in its portfolio. Navellier And Assoc Inc has invested 0.52% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Commonwealth Financial Bank Of Australia holds 0% in IDEXX Laboratories, Inc. (NASDAQ:IDXX) or 893 shares. Cibc World Mkts invested in 0.04% or 38,416 shares. Eulav Asset Mgmt accumulated 1.9% or 177,700 shares. The New Jersey-based Fincl Architects has invested 0.02% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Bremer Trust Natl Association holds 1,228 shares. Meiji Yasuda Asset Mgmt Limited holds 0.02% or 1,160 shares.

Among 11 analysts covering IDEXX Laboratories (NASDAQ:IDXX), 7 have Buy rating, 2 Sell and 2 Hold. Therefore 64% are positive. IDEXX Laboratories had 35 analyst reports since July 24, 2015 according to SRatingsIntel. Credit Suisse maintained it with “Outperform” rating and $231 target in Thursday, June 21 report. The firm has “Buy” rating given on Friday, July 28 by C.L. King. The firm has “Buy” rating given on Wednesday, July 20 by Canaccord Genuity. Canaccord Genuity maintained it with “Buy” rating and $180.0 target in Thursday, October 5 report. The stock has “Outperform” rating by Credit Suisse on Friday, August 17. The company was downgraded on Friday, August 28 by Raymond James. The rating was upgraded by Feltl & Co on Friday, July 24 to “Hold”. The stock of IDEXX Laboratories, Inc. (NASDAQ:IDXX) has “Outperform” rating given on Friday, June 1 by Credit Suisse. The firm has “Outperform” rating given on Wednesday, April 13 by Credit Suisse. The company was maintained on Tuesday, June 13 by Canaccord Genuity.

Since August 21, 2018, it had 1 insider purchase, and 8 insider sales for $25.31 million activity. 2,405 shares valued at $501,875 were bought by Kingsley Lawrence D on Tuesday, February 5. On Tuesday, August 21 the insider Studer Jacqueline sold $2.84M. On Wednesday, February 6 the insider TWIGGE GIOVANI sold $208,454. $682,992 worth of IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares were sold by HENDERSON REBECCA M. 30,000 shares valued at $7.37M were sold by AYERS JONATHAN W on Tuesday, August 21.

Among 43 analysts covering CBS Corp (NYSE:CBS), 28 have Buy rating, 0 Sell and 15 Hold. Therefore 65% are positive. CBS Corp had 131 analyst reports since August 6, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Tuesday, January 2 by Macquarie Research. The stock of CBS Corporation (NYSE:CBS) earned “Neutral” rating by Atlantic Securities on Monday, February 11. The stock of CBS Corporation (NYSE:CBS) earned “Buy” rating by Citigroup on Thursday, February 22. Goldman Sachs initiated it with “Hold” rating and $5900 target in Thursday, November 29 report. The stock of CBS Corporation (NYSE:CBS) has “Outperform” rating given on Friday, January 20 by Credit Suisse. The rating was maintained by BMO Capital Markets on Monday, September 11 with “Buy”. The firm has “Buy” rating given on Tuesday, September 6 by Drexel Hamilton. On Friday, May 4 the stock rating was maintained by Wells Fargo with “Hold”. The firm has “Hold” rating by Pivotal Research given on Thursday, January 12. The rating was maintained by BMO Capital Markets with “Buy” on Wednesday, April 25.

More notable recent CBS Corporation (NYSE:CBS) news were published by: Seekingalpha.com which released: “Desus & Mero Drive Showtime Growth And CBS Stock – Seeking Alpha” on January 28, 2019, also Fool.com with their article: “Why CBS Stock Gained 13% in January – Motley Fool” published on February 07, 2019, Benzinga.com published: “Earnings Scheduled For February 14, 2019 – Benzinga” on February 14, 2019. More interesting news about CBS Corporation (NYSE:CBS) were released by: Bizjournals.com and their article: “Ousted CBS chief Moonvess to fight for his $120M severance package – Bizwomen – The Business Journals” published on January 18, 2019 as well as Seekingalpha.com‘s news article titled: “Analyst: CBS, Viacom sure to merge this year – Seeking Alpha” with publication date: January 17, 2019.

Since September 6, 2018, it had 0 insider buys, and 4 insider sales for $2.22 million activity.

CBS Corporation (NYSE:CBS) Institutional Positions Chart